These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 17970760)
1. Rosiglitazone prevents diabetes by increasing beta-cell mass in an animal model of type 2 diabetes characterized by reduced beta-cell mass at birth. Holloway AC; Petrik JJ; Bruin JE; Gerstein HC Diabetes Obes Metab; 2008 Sep; 10(9):763-71. PubMed ID: 17970760 [TBL] [Abstract][Full Text] [Related]
2. Fetal and neonatal nicotine exposure and postnatal glucose homeostasis: identifying critical windows of exposure. Bruin JE; Kellenberger LD; Gerstein HC; Morrison KM; Holloway AC J Endocrinol; 2007 Jul; 194(1):171-8. PubMed ID: 17592031 [TBL] [Abstract][Full Text] [Related]
3. Effect of combining rosiglitazone with either metformin or insulin on β-cell mass and function in an animal model of Type 2 diabetes characterized by reduced β-cell mass at birth. Holloway AC; Hettinga BP; Gerstein HC J Diabetes; 2011 Mar; 3(1):74-81. PubMed ID: 21040499 [TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone inhibits early stage of glucolipotoxicity-induced beta-cell apoptosis. Han SJ; Kang ES; Hur KY; Kim HJ; Kim SH; Yun CO; Choi SE; Ahn CW; Cha BS; Kang Y; Lee HC Horm Res; 2008; 70(3):165-73. PubMed ID: 18663317 [TBL] [Abstract][Full Text] [Related]
5. Effect of chronic rosiglitazone, metformin and glyburide treatment on beta-cell mass, function and insulin sensitivity in mZDF rats. Atkinson LL; McDonald-Dyck C; Benkoczi C; Finegood DT Diabetes Obes Metab; 2008 Sep; 10(9):780-90. PubMed ID: 17970758 [TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone improves pancreatic mitochondrial function in an animal model of dysglycemia: role of the insulin-like growth factor axis. Bruin JE; Petrik JJ; Hyslop JR; Raha S; Tarnopolsky MA; Gerstein HC; Holloway AC Endocrine; 2010 Apr; 37(2):303-11. PubMed ID: 20960268 [TBL] [Abstract][Full Text] [Related]
7. Fetal and neonatal nicotine exposure in Wistar rats causes progressive pancreatic mitochondrial damage and beta cell dysfunction. Bruin JE; Petre MA; Raha S; Morrison KM; Gerstein HC; Holloway AC PLoS One; 2008; 3(10):e3371. PubMed ID: 18852877 [TBL] [Abstract][Full Text] [Related]
8. Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling period. Calderari S; Gangnerau MN; Meile MJ; Portha B; Serradas P Pancreas; 2006 Nov; 33(4):412-7. PubMed ID: 17079948 [TBL] [Abstract][Full Text] [Related]
9. Beta-cell function and mass in type 2 diabetes. Larsen MO Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971 [TBL] [Abstract][Full Text] [Related]
10. Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes. Holloway AC; Lim GE; Petrik JJ; Foster WG; Morrison KM; Gerstein HC Diabetologia; 2005 Dec; 48(12):2661-6. PubMed ID: 16270195 [TBL] [Abstract][Full Text] [Related]
11. Increased pancreatic beta-cell apoptosis following fetal and neonatal exposure to nicotine is mediated via the mitochondria. Bruin JE; Gerstein HC; Morrison KM; Holloway AC Toxicol Sci; 2008 Jun; 103(2):362-70. PubMed ID: 18203686 [TBL] [Abstract][Full Text] [Related]
12. Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. ; Dagenais GR; Gerstein HC; Holman R; Budaj A; Escalante A; Hedner T; Keltai M; Lonn E; McFarlane S; McQueen M; Teo K; Sheridan P; Bosch J; Pogue J; Yusuf S Diabetes Care; 2008 May; 31(5):1007-14. PubMed ID: 18268075 [TBL] [Abstract][Full Text] [Related]
13. Exposure of the pregnant rat to low protein diet causes impaired glucose homeostasis in the young adult offspring by different mechanisms in males and females. Chamson-Reig A; Thyssen SM; Hill DJ; Arany E Exp Biol Med (Maywood); 2009 Dec; 234(12):1425-36. PubMed ID: 19657071 [TBL] [Abstract][Full Text] [Related]
14. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity. Ghanaat-Pour H; Sjöholm A Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603 [TBL] [Abstract][Full Text] [Related]
15. Early administration of keratinocyte growth factor improves {beta}-cell regeneration in rat with streptozotocin-induced diabetes. Movassat J; Portha B J Endocrinol; 2007 Nov; 195(2):333-40. PubMed ID: 17951544 [TBL] [Abstract][Full Text] [Related]
16. Protection of pancreatic beta-cells: is it feasible? Bonora E Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375 [TBL] [Abstract][Full Text] [Related]
17. Concurrently using rosiglitazone prevents glucosamine-induced islet beta-cell apoptosis and dysfunction. Zhang X; Tong N; Li Y Cell Biochem Funct; 2010 Aug; 28(6):509-14. PubMed ID: 20803707 [TBL] [Abstract][Full Text] [Related]
18. Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences. Lupi R; Del Prato S Diabetes Metab; 2008 Feb; 34 Suppl 2():S56-64. PubMed ID: 18640587 [TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone protects the pancreatic beta-cell death induced by cyclosporine A. Kim JW; Yang JH; Park HS; Sun C; Lee SH; Cho JH; Yang CW; Yoon KH Biochem Biophys Res Commun; 2009 Dec; 390(3):763-8. PubMed ID: 19836348 [TBL] [Abstract][Full Text] [Related]